SNCA and Parkinson disease: Although there is no direct evidence for the role of DNA damage in astrocytic neurotoxicity in PD, considering the potential damaging effects of inflammatory factors and pathogenic α-synuclein on astrocytic genomic DNA [128,135,138], it is conceivable that DNA damage may be an important part of astrocytic activation and toxic amplification in PD.